CN105561269A - Method for preparing traditional Chinese medicine fumigation liniment for treating postpartum uroschesis - Google Patents
Method for preparing traditional Chinese medicine fumigation liniment for treating postpartum uroschesis Download PDFInfo
- Publication number
- CN105561269A CN105561269A CN201610043478.1A CN201610043478A CN105561269A CN 105561269 A CN105561269 A CN 105561269A CN 201610043478 A CN201610043478 A CN 201610043478A CN 105561269 A CN105561269 A CN 105561269A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- liniment
- parts
- urine
- officinalis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a method for preparing traditional Chinese medicine fumigation liniment for treating postpartum uroschesis. The traditional Chinese medicine fumigation liniment is prepared from cortex magnoliae officinalis, cape jasmine fruits, fructus sophorae, dried ginger and radix morinda officinalis. The traditional Chinese medicine fumigation liniment prepared through the method is extremely remarkable in curative effect when used for treating a patient suffering from postpartum uroschesis and easy to apply, meanwhile, the number of days when the patient stays in hospital is decreased, psychic pain of the patient is relieved, and economical burden of the patient is also alleviated.
Description
The application is the divisional application of the application for a patent for invention (denomination of invention is: a kind of pharmaceutical composition for the treatment of postpartum retention of urine, and application number is: 2014100707991, and the applying date is: on February 28th, 2014) that applicant Cui Xinming proposes.
Technical field
The invention belongs to Chinese medicine nursing technique field, be specifically related to a kind of method preparing the herbal fumigation liniment for the treatment of postpartum retention of urine.
Background technology
Postpartum retention of urine is the common complication of obstetrics, incidence rate 7%-10%.Postpartum retention of urine refers to that 6-8h filling of bladder in puerperal can not Self-discharged urine, generation dysuria and row's urine retention.Puerperal once there is urine retention in puerpera, and full bladder compressing uterus, causes uterine contraction bad, occur postpartum hemorrhage.The hemorrhage anxiety of puerpera, impact feed and sleep, and poor sleep affects the secretion of breast amount, makes puerpera can not accomplish suckling as required, affects neonatal growth promoter; In addition, because dysuria in puerperal causes psychentonia, be easy to bring out mental disorder.So puerperal should empty bladder as early as possible, reduces the incidence rate of postpartum hemorrhage, increases comfort level in puerperal, promote postpartum recovery.
At present, the Therapeutic Method for puerpera's postpartum retention of urine comprises conventional induced uresis method, Catheterization, acupuncture method, finger pressure diuresis cave method.Conventional induced uresis method as hot compress, massage, listen the induction ratio juris such as the underwater sound to be by massage pushing, reaching reflexive stimulates detrusor of bladder to shrink to cause and urinate, but less effective, and has the possibility causing rupture of bladder; The danger that Catheterization causes suffering to puerpera and infects; The methods such as acupuncture and moxibustion therapy, finger pressure diuresis cave, comparatively bother and require efforts.
Summary of the invention
In view of the deficiencies in the prior art, the object of the present invention is to provide a kind of pharmaceutical composition for the treatment of postpartum retention of urine evident in efficacy.In order to realize object of the present invention, inventor continues research and explores on the basis of secret prescription handed down in the family from generation to generation, finally obtains following technical scheme:
Treat a pharmaceutical composition for postpartum retention of urine, by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: Cortex Magnoliae Officinalis 23-30 part, Fructus Gardeniae 21-30 part, Fructus Sophorae 32-45 part, Rhizoma Zingiberis 6-10 part, Radix Morindae Officinalis 6-12 part.
Preferably, the pharmaceutical composition for the treatment of postpartum retention of urine as mentioned above, by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: Cortex Magnoliae Officinalis 25-27 part, Fructus Gardeniae 24-26 part, Fructus Sophorae 36-40 part, Rhizoma Zingiberis 7-9 part, Radix Morindae Officinalis 8-10 part.
Further preferably, the pharmaceutical composition for the treatment of postpartum retention of urine as mentioned above, by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: Cortex Magnoliae Officinalis 26 parts, Fructus Gardeniae 25 parts, the Fructus Sophorae 38 parts, Rhizoma Zingiberis 8 parts, Radix Morindae Officinalis 9 parts.
Further preferably, the pharmaceutical composition for the treatment of postpartum retention of urine as mentioned above, by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: Cortex Magnoliae Officinalis 23 parts, Fructus Gardeniae 30 parts, the Fructus Sophorae 32 parts, Rhizoma Zingiberis 6 parts, Radix Morindae Officinalis 8 parts.
Further preferably, the pharmaceutical composition for the treatment of postpartum retention of urine as mentioned above, by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: Cortex Magnoliae Officinalis 30 parts, Fructus Gardeniae 21 parts, the Fructus Sophorae 40 parts, Rhizoma Zingiberis 10 parts, Radix Morindae Officinalis 6 parts.
Further preferably, the pharmaceutical composition for the treatment of postpartum retention of urine as mentioned above, by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: Cortex Magnoliae Officinalis 25 parts, Fructus Gardeniae 25 parts, the Fructus Sophorae 45 parts, Rhizoma Zingiberis 8 parts, Radix Morindae Officinalis 10 parts.
The pharmaceutical composition of fumigation in treating postpartum retention of urine of the present invention can be prepared into powder, and method is: take Cortex Magnoliae Officinalis 23-30 part, Fructus Gardeniae 21-30 part, Fructus Sophorae 32-45 part, Rhizoma Zingiberis 6-10 part and Radix Morindae Officinalis 6-12 part, cleans roguing, dry, be ground into granule, pulverization, subpackage.
Found by Multitest research and a large amount of clinical practice, pharmaceutical composition of the present invention is by the curative effect highly significant to puerpera's postpartum retention of urine after stifling scouring treatment.Therefore, second object of the present invention is to provide a kind of pharmaceutical applications, i.e. the application of aforementioned pharmaceutical compositions in the external used medicine of preparation treatment puerpera postpartum retention of urine.
Compared with prior art, pharmaceutical composition of the present invention adopts stifling mode of cleaning to be used for the treatment of postpartum retention of urine patient, and its curative effect is very remarkable, apply also simple and easy to do, can avoid will inserting urinary catheter because of urine retention, the danger causing suffering to puerpera and infect, more easily by patient is accepted; Reduce length of stay simultaneously, both relieved patient mental's misery, also mitigate the financial burden of patient.
Detailed description of the invention
It should be noted that, traditional Chinese medicinal material raw materials of the present invention has following source: Cortex Magnoliae Officinalis selects the dry dried bark of Magnoliacea plant Cortex Magnoliae Officinalis MagnoliaofficinalisRehd.etWils. or magnolia officinalis rehd.et wils.var.biloba rehd.et wils. MagnoliaofficinalisRehd.etWils.var.bilobaRehd.etWils., root bark and branch skin; Fructus Gardeniae selects the dry mature fruit of Maguireothamnus speciosus Fructus Gardeniae GardeniajasminoidesEllis; The Fructus Sophorae selects the dry mature fruit of leguminous plant Chinese scholartree SophorajaponicaL.; Rhizoma Zingiberis selects the dry rhizome of zingiber ZingiberofficinaleRosc.; Radix Morindae Officinalis selects the dry root of Maguireothamnus speciosus Radix Morindae Officinalis MorindaofficinalisHow.
Be below specific embodiments of the invention, technical scheme of the present invention is done to describing further, but protection scope of the present invention be not limited to these embodiments.Every do not deviate from the present invention's design change or equivalent substituting include within protection scope of the present invention.
embodiment 1
Crude drug prescription: Cortex Magnoliae Officinalis 0.26 kilogram, Fructus Gardeniae 0.25 kilogram, the Fructus Sophorae 0.38 kilogram, Rhizoma Zingiberis 0.08 kilogram, Radix Morindae Officinalis 0.09 kilogram.
Preparation method: take above-mentioned Chinese crude drug, cleans roguing, dries, be ground into granule, pulverization, by every bag of 100 grams of subpackages.
embodiment 2
Crude drug prescription: Cortex Magnoliae Officinalis 0.23 kilogram, Fructus Gardeniae 0.3 kilogram, the Fructus Sophorae 0.32 kilogram, Rhizoma Zingiberis 0.06 kilogram, Radix Morindae Officinalis 0.08 kilogram.
Preparation method: take above-mentioned Chinese crude drug, cleans roguing, dries, be ground into granule, pulverization, by every bag of 100 grams of subpackages.
embodiment 3
Crude drug prescription: Cortex Magnoliae Officinalis 0.3 kilogram, Fructus Gardeniae 0.21 kilogram, the Fructus Sophorae 0.4 kilogram, Rhizoma Zingiberis 0.1 kilogram, Radix Morindae Officinalis 0.06 kilogram.
Preparation method: take above-mentioned Chinese crude drug, cleans roguing, dries, be ground into granule, pulverization, by every bag of 100 grams of subpackages.
embodiment 4
Crude drug prescription: Cortex Magnoliae Officinalis 0.25 kilogram, Fructus Gardeniae 0.25 kilogram, the Fructus Sophorae 0.45 kilogram, Rhizoma Zingiberis 0.08 kilogram, Radix Morindae Officinalis 0.1 kilogram.
Preparation method: take above-mentioned Chinese crude drug, cleans roguing, dries, be ground into granule, pulverization, by every bag of 100 grams of subpackages.
the clinical trial example of embodiment 5 treatment by Chinese herbs postpartum retention of urine puerpera
There is childbirth puerpera 42 example of postpartum retention of urine, age 21-30 year, 26.1 ± 0.8 years old mean age, pregnant all 37-41 week, in average (38.7 ± 1.1) week, being primipara's row lateral episiotomy produces, the sick and protopathy of foundation-free.All puerperas are divided into matched group (21 example) at random, and test group (21 example), two groups of there was no significant differences in age, pregnant cycle and the state of an illness etc., have comparability.
Two groups of puerpera's routines give to instruct puerperal, and matched group adopts conventional treatment, that is: abdominal massaging, pudendum hot water injection, listen 30min singing of the stream induced uresis.Test group is aided with rapidly herbal fumigation and cleans on above-mentioned processed conventionally basis, and prescription consists of: Cortex Magnoliae Officinalis 26g, Fructus Gardeniae 25g, Fructus Sophorae 38g, Rhizoma Zingiberis 8g, Radix Morindae Officinalis 9g.Fumigation and wash method method: Chinese crude drug prescription is decocted 1.5 hours, remove decocting liquid 2L, the height of falling people foot cleans bedpan, bedpan is that a people one cleans with one, be cooled to about 45 DEG C airtight sitting postures and fumigate lOmin, just urinate completely when 13 routine puerperas fumigate, and then clean 5-10min after non-row person and non-emptying person fumigate and all can urinate completely.Concrete result of the test is in table 1.
Table l matched group compares (example) with test group treatment effect
Claims (3)
1. prepare a method for the herbal fumigation liniment for the treatment of postpartum retention of urine, it is characterized in that comprising following processing step: take following traditional Chinese medicinal material raw materials by weight: Cortex Magnoliae Officinalis 23-30 part, Fructus Gardeniae 21-30 part, Fructus Sophorae 32-45 part, Rhizoma Zingiberis 6-10 part, Radix Morindae Officinalis 6-12 part; Above-mentioned raw materials is cleaned roguing, dries, be ground into granule, pulverization, by every bag of 100 grams of subpackages, to obtain final product.
2. the method for the herbal fumigation liniment of preparation treatment postpartum retention of urine according to claim 1, is characterized in that: described pharmaceutical composition is prepared from by the traditional Chinese medicinal material raw materials of following weight portion: Cortex Magnoliae Officinalis 25-27 part, Fructus Gardeniae 24-26 part, Fructus Sophorae 36-40 part, Rhizoma Zingiberis 7-9 part, Radix Morindae Officinalis 8-10 part.
3. the method for the herbal fumigation liniment of preparation treatment postpartum retention of urine according to claim 1 and 2, is characterized in that: described pharmaceutical composition is prepared from by the traditional Chinese medicinal material raw materials of following weight portion: Cortex Magnoliae Officinalis 26 parts, Fructus Gardeniae 25 parts, the Fructus Sophorae 38 parts, Rhizoma Zingiberis 8 parts, Radix Morindae Officinalis 9 parts.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410070799.1A CN103830697B (en) | 2014-02-28 | 2014-02-28 | A kind of pharmaceutical composition for the treatment of postpartum retention of urine |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410070799.1A Division CN103830697B (en) | 2014-02-28 | 2014-02-28 | A kind of pharmaceutical composition for the treatment of postpartum retention of urine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105561269A true CN105561269A (en) | 2016-05-11 |
Family
ID=50794799
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610043465.4A Withdrawn CN105497858A (en) | 2014-02-28 | 2014-02-28 | Medicine composition for treating postpartum urinary retention |
| CN201410070799.1A Active CN103830697B (en) | 2014-02-28 | 2014-02-28 | A kind of pharmaceutical composition for the treatment of postpartum retention of urine |
| CN201610043473.9A Withdrawn CN105497860A (en) | 2014-02-28 | 2014-02-28 | Application of medicine composition to preparation of externally used medicine for treating postpartum urinary retention of parturient women |
| CN201610043469.2A Withdrawn CN105497859A (en) | 2014-02-28 | 2014-02-28 | Medicine composition for treating postpartum urinary retention |
| CN201610043478.1A Withdrawn CN105561269A (en) | 2014-02-28 | 2014-02-28 | Method for preparing traditional Chinese medicine fumigation liniment for treating postpartum uroschesis |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610043465.4A Withdrawn CN105497858A (en) | 2014-02-28 | 2014-02-28 | Medicine composition for treating postpartum urinary retention |
| CN201410070799.1A Active CN103830697B (en) | 2014-02-28 | 2014-02-28 | A kind of pharmaceutical composition for the treatment of postpartum retention of urine |
| CN201610043473.9A Withdrawn CN105497860A (en) | 2014-02-28 | 2014-02-28 | Application of medicine composition to preparation of externally used medicine for treating postpartum urinary retention of parturient women |
| CN201610043469.2A Withdrawn CN105497859A (en) | 2014-02-28 | 2014-02-28 | Medicine composition for treating postpartum urinary retention |
Country Status (1)
| Country | Link |
|---|---|
| CN (5) | CN105497858A (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104147184B (en) * | 2014-08-28 | 2015-04-01 | 时均燕 | Medicine for nursing of postpartum urinary retention |
| CN104436104A (en) * | 2014-11-07 | 2015-03-25 | 黄萍 | Method for preparing traditional Chinese medicine for treating anuresis |
| CN104474211A (en) * | 2014-12-03 | 2015-04-01 | 祝彩云 | Traditional Chinese medicine lotion for treating postpartum urinary retention |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101152367A (en) * | 2007-09-17 | 2008-04-02 | 尹克山 | Traditional Chinese medicine for treating pregnancy urinary retention |
| CN101623411A (en) * | 2008-07-11 | 2010-01-13 | 北京天科仁祥医药科技有限公司 | Chinese medicament for resisting bacteria and diminishing inflammation, clearing away heat and toxic material, and removing blood stasis and relieving pain |
| CN101637592B (en) * | 2009-07-10 | 2011-07-13 | 李小平 | Diuresis antibiotic pill |
| CN102228603B (en) * | 2011-06-16 | 2012-08-29 | 莫忆鸣 | Chinese medicine for treating retention of urine |
| CN102836225A (en) * | 2011-06-23 | 2012-12-26 | 王东 | Traditional Chinese drug preparation for treating postpartum urine retention |
| CN102552857A (en) * | 2012-02-13 | 2012-07-11 | 李承平 | Capsule for removing blood stasis for promoting tissue regeneration after childbirth |
| CN102847058B (en) * | 2012-04-10 | 2013-10-16 | 于泳 | Pharmaceutical composition for treating urinary retention after caesarean section |
| CN103505643B (en) * | 2012-06-17 | 2015-03-11 | 高霞 | Medicament for treating postpartum urinary retention |
| CN103110766A (en) * | 2013-03-23 | 2013-05-22 | 徐姝一 | Traditional Chinese medical composition for treating postpartum urinary retention |
-
2014
- 2014-02-28 CN CN201610043465.4A patent/CN105497858A/en not_active Withdrawn
- 2014-02-28 CN CN201410070799.1A patent/CN103830697B/en active Active
- 2014-02-28 CN CN201610043473.9A patent/CN105497860A/en not_active Withdrawn
- 2014-02-28 CN CN201610043469.2A patent/CN105497859A/en not_active Withdrawn
- 2014-02-28 CN CN201610043478.1A patent/CN105561269A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN105497860A (en) | 2016-04-20 |
| CN103830697B (en) | 2016-03-02 |
| CN105497858A (en) | 2016-04-20 |
| CN103830697A (en) | 2014-06-04 |
| CN105497859A (en) | 2016-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101095785B (en) | Chinese traditional medicine composition for treating arthritis hyperosteogeny intervertebral disc protrusion | |
| CN103341064B (en) | Chinese medicine composition for treating urine retention | |
| CN105148172A (en) | Traditional Chinese medicine decoction for treating dyspepsia | |
| CN107929629A (en) | One kind prolongs age and consolidates ball and preparation method thereof | |
| CN102008610B (en) | Traditional Chinese medicine composition for curing hyperosteogeny | |
| CN103830697B (en) | A kind of pharmaceutical composition for the treatment of postpartum retention of urine | |
| CN102078435B (en) | Medicinal oil for treating pityriasis rosea and preparation method thereof | |
| CN103285300B (en) | Medicinal composition for treating stress incontinence | |
| CN105477302A (en) | Insomnia treating traditional Chinese medicine composition and preparation method thereof | |
| CN105641656A (en) | Medicine composition for treating postpartum uroschesis | |
| CN103495069B (en) | Pharmaceutical composition for treating postpartum neurosis intestinal obstruction | |
| CN103285243B (en) | Granules for treating hyperglycemia | |
| CN108042622A (en) | A kind of Chinese medicine composition for treating osteoproliferation, arthralgia and preparation method thereof | |
| CN106668604A (en) | Medicinal wine capable of dispersing pathogenic wind and strengthening yang and preparation method thereof | |
| CN105664093A (en) | Application of pharmaceutical composition to preparation of externally-applied medicine for treating postpartum urinary retention | |
| CN105664094A (en) | Application of pharmaceutical composition to preparation of externally-applied medicine for treating postpartum urinary retention | |
| CN105395908A (en) | Application of medicine composition in preparing medicine for treating rheumatic arthritis | |
| CN104306686A (en) | Externally applied medicine for treating leukoderma | |
| CN103520541B (en) | Dressing umbilicus granule for treating postnatal neurosis intestinal obstruction and preparation method thereof | |
| CN104435734A (en) | Traditional Chinese medicine preparation for nursing uterine leiomyoma and preparation method of traditional Chinese medicine preparation | |
| CN104491560B (en) | A kind of oral drugs for treating postpartum Cherchevski's | |
| CN103285301B (en) | Method for preparing umbilicus dressing agent for treating stress incontinence | |
| CN103341108A (en) | Pharmaceutical composite for treating stress urinary incontinence after prostatectomy | |
| CN103301372A (en) | Preparation method of umbilicus dressing agent for treating post-operation prostate stress urinary incontinence | |
| CN106492106A (en) | A kind of medicated wine of wind-damp dispelling and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Jingyun Inventor after: Dong Wenju Inventor before: Dong Wenju |
|
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160511 |
|
| WW01 | Invention patent application withdrawn after publication |